ArticleFrontiers in pharmacology2023

Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.